{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:19:51Z","timestamp":1794367191054,"version":"4.9.0"},"reference-count":30,"publisher":"American Association for Cancer Research (AACR)","issue":"10","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the progress made in our understanding of the biology of neurofibromatosis (NF), the long-term clinical outcome for affected patients has not changed significantly in the past decades, and both NF1 and NF2 are still associated with a significant morbidity and a decreased life span. A number of NF1 and NF2 murine models have been generated to aid in the study of NF tumor biology and in the development of targeted therapies for NF patients. A single, universal pathological classification of the lesions generated in these murine models is essential for the validation of the models, for their analysis and comparison with other models, and for their future effective use in preclinical treatment trials. For the formulation of a pathological classification of these lesions, the WHO classification of human tumors was used as a reference. However, it was not adopted for the classification of the GEM lesions because of some important differences between the human and murine lesions. A novel classification scheme for peripheral nerve sheath tumors in murine models was therefore devised.<\/jats:p>","DOI":"10.1158\/0008-5472.can-03-4079","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T22:38:29Z","timestamp":1127255909000},"page":"3718-3724","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Comparative Pathology of Nerve Sheath Tumors in Mouse Models and Humans"],"prefix":"10.1158","volume":"64","author":[{"given":"Anat O.","family":"Stemmer-Rachamimov","sequence":"first","affiliation":[{"name":"1Departments of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Louis","sequence":"additional","affiliation":[{"name":"1Departments of Pathology and"},{"name":"14Massachusetts General Hospital Cancer Center, Harvard Medical School Department of Pathology, Charlestown, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnlaugur P.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"1Departments of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Antonescu","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Borowsky","sequence":"additional","affiliation":[{"name":"4Medical Pathology Center for Comparative Medicine, University of California at Davis, Davis, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick T.","family":"Bronson","sequence":"additional","affiliation":[{"name":"5Department of Pathology, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K.","family":"Burns","sequence":"additional","affiliation":[{"name":"6Department of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Cervera","sequence":"additional","affiliation":[{"name":"8INSERM U434, Fondation Jean Dausset-CEPH, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"9Department of Pathology, Brigham and Women\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Reifenberger","sequence":"additional","affiliation":[{"name":"10Department of Neuropathology, Heinrich-Heine-University, Duesseldorf, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Schmale","sequence":"additional","affiliation":[{"name":"11Division of Marine Biology and Fisheries, Rosenstiel School of Marine and Atmospheric Science, University of Miami, Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"MacCollin","sequence":"additional","affiliation":[{"name":"2Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Chao","sequence":"additional","affiliation":[{"name":"12Department of Medicine, Veterans\u2019 Affairs Medical Center and University of California at San Francisco, San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Cichowski","sequence":"additional","affiliation":[{"name":"13Genetics Division, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kalamarides","sequence":"additional","affiliation":[{"name":"8INSERM U434, Fondation Jean Dausset-CEPH, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta M.","family":"Messerli","sequence":"additional","affiliation":[{"name":"2Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea I.","family":"McClatchey","sequence":"additional","affiliation":[{"name":"14Massachusetts General Hospital Cancer Center, Harvard Medical School Department of Pathology, Charlestown, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Niwa-Kawakita","sequence":"additional","affiliation":[{"name":"8INSERM U434, Fondation Jean Dausset-CEPH, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Ratner","sequence":"additional","affiliation":[{"name":"15Department of Cell Biology, Neurobiology, and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlyne M.","family":"Reilly","sequence":"additional","affiliation":[{"name":"16Genetic Modifiers of Tumorigenesis Section, Mouse Cancer Genetics Program, National Cancer Institute at Frederick, Frederick, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"7Center for Developmental Biology, University of Texas Southwestern Medical Center, Dallas, Texas;"},{"name":"17Division of Molecular Medicine and Genetics, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Giovannini","sequence":"additional","affiliation":[{"name":"8INSERM U434, Fondation Jean Dausset-CEPH, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,5,17]]},"reference":[{"key":"2022061620092067700_B1","unstructured":"Friedman JM, Gutmann DH, MacCollin M, Riccardi VM . Neurofibromatosis: phenotype, natural history, and pathogenesis, 3rd ed The Johns Hopkins University Press Baltimore, MD \u20081999."},{"key":"2022061620092067700_B2","unstructured":"Louis DN, Stemmer-Rachamimov AO, Wiestler OD Neurofibromatosis type 2 Kleihues P Cavenee W. K. eds. . Pathology and genetics of tumours of the nervous system, 219-22, IARC Lyon, France \u20082000."},{"key":"2022061620092067700_B3","unstructured":"Evans DG, Huson SM, Donnai D, et al A clinical study of type 2 neurofibromatosis. Q J Med, 84:\u2008603-18, \u20081992."},{"key":"2022061620092067700_B4","doi-asserted-by":"crossref","unstructured":"Rasmussen SA, Yang Q, Friedman JM Mortality in neurofibromatosis 1: an analysis using U. S. death certificates. Am J Hum Genet, 68:\u20081110-8, \u20082001.","DOI":"10.1086\/320121"},{"key":"2022061620092067700_B5","doi-asserted-by":"crossref","unstructured":"Zoller M, Rembeck B, Akesson HO, Angervall L Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Derm Venereol, 75:\u2008136-40, \u20081995.","DOI":"10.2340\/0001555575136140"},{"key":"2022061620092067700_B6","doi-asserted-by":"crossref","unstructured":"Perry A, Roth KA, Banerjee R, Fuller CE, Gutmann DH NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am J Pathol, 159:\u200857-61, \u20082001.","DOI":"10.1016\/S0002-9440(10)61673-2"},{"key":"2022061620092067700_B7","doi-asserted-by":"crossref","unstructured":"Baser ME, Evans DG, Gutmann DH Neurofibromatosis 2. Curr Opin Neurol, 16:\u200827-33, \u20082003.","DOI":"10.1097\/00019052-200302000-00004"},{"key":"2022061620092067700_B8","doi-asserted-by":"crossref","unstructured":"McClatchey AI, Saotome I, Ramesh V, Gusella JF, Jacks T The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev, 11:\u20081253-65, \u20081997.","DOI":"10.1101\/gad.11.10.1253"},{"key":"2022061620092067700_B9","doi-asserted-by":"crossref","unstructured":"Brannan CI, Perkins AS, Vogel KS, et al Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev, 8:\u20081019-29, \u20081994.","DOI":"10.1101\/gad.8.9.1019"},{"key":"2022061620092067700_B10","doi-asserted-by":"crossref","unstructured":"Jacks T, Shih TS, Schmitt EM, et al Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet, 7:\u2008353-61, \u20081994.","DOI":"10.1038\/ng0794-353"},{"key":"2022061620092067700_B11","doi-asserted-by":"crossref","unstructured":"Lakkis MM, Epstein JA Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development (Camb), 125:\u20084359-67, \u20081998.","DOI":"10.1242\/dev.125.22.4359"},{"key":"2022061620092067700_B12","doi-asserted-by":"crossref","unstructured":"Lakkis MM, Golden JA, O\u2019Shea KS, Epstein JA Neurofibromin deficiency in mice causes exencephaly and is a modifier for Splotch neural tube defects. Dev Biol, 212:\u200880-92, \u20081999.","DOI":"10.1006\/dbio.1999.9327"},{"key":"2022061620092067700_B13","doi-asserted-by":"crossref","unstructured":"McClatchey AI, Saotome I, Mercer K, et al Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev, 12:\u20081121-33, \u20081998.","DOI":"10.1101\/gad.12.8.1121"},{"key":"2022061620092067700_B14","doi-asserted-by":"crossref","unstructured":"Giovannini M, Robanus-Maandag E, van der Valk M, et al Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev, 14:\u20081617-30, \u20082000.","DOI":"10.1101\/gad.14.13.1617"},{"key":"2022061620092067700_B15","doi-asserted-by":"crossref","unstructured":"Bajenaru ML, Donahoe J, Corral T, et al Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia, 33:\u2008314-23, \u20082001.","DOI":"10.1002\/1098-1136(20010315)33:4<314::AID-GLIA1030>3.0.CO;2-Q"},{"key":"2022061620092067700_B16","doi-asserted-by":"crossref","unstructured":"Gutmann DH, Loehr A, Zhang Y, et al Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene, 18:\u20084450-9, \u20081999.","DOI":"10.1038\/sj.onc.1202829"},{"key":"2022061620092067700_B17","doi-asserted-by":"crossref","unstructured":"Costa RM, Federov NB, Kogan JH, et al Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature (Lond), 415:\u2008526-30, \u20082002.","DOI":"10.1038\/nature711"},{"key":"2022061620092067700_B18","doi-asserted-by":"crossref","unstructured":"Silva AJ, Frankland PW, Marowitz Z, et al A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet, 15:\u2008281-4, \u20081997.","DOI":"10.1038\/ng0397-281"},{"key":"2022061620092067700_B19","doi-asserted-by":"crossref","unstructured":"Cichowski K, Shih TS, Schmitt E, et al Mouse models of tumor development in neurofibromatosis type 1. Science (Wash DC), 286:\u20082172-6, \u20081999.","DOI":"10.1126\/science.286.5447.2172"},{"key":"2022061620092067700_B20","doi-asserted-by":"crossref","unstructured":"Bajenaru ML, Zhu Y, Hedrick NM, et al Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol, 22:\u20085100-13, \u20082002.","DOI":"10.1128\/MCB.22.14.5100-5113.2002"},{"key":"2022061620092067700_B21","doi-asserted-by":"crossref","unstructured":"Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science (Wash DC), 296:\u2008920-2, \u20082002.","DOI":"10.1126\/science.1068452"},{"key":"2022061620092067700_B22","doi-asserted-by":"crossref","unstructured":"Kalamarides M, Niwa-Kawakita M, Leblois H, et al Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev, 16:\u20081060-5, \u20082002.","DOI":"10.1101\/gad.226302"},{"key":"2022061620092067700_B23","doi-asserted-by":"crossref","unstructured":"Costa RM, Yang T, Huynh DP, et al Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet, 27:\u2008399-405, \u20082001.","DOI":"10.1038\/86898"},{"key":"2022061620092067700_B24","doi-asserted-by":"crossref","unstructured":"Giovannini M, Robanus-Maandag E, Niwa-Kawakita M, et al Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev, 13:\u2008978-86, \u20081999.","DOI":"10.1101\/gad.13.8.978"},{"key":"2022061620092067700_B25","doi-asserted-by":"crossref","unstructured":"Vogel KS, Klesse LJ, Velasco-Miguel S, et al Mouse tumor model for neurofibromatosis type 1. Science (Wash DC), 286:\u20082176-9, \u20081999.","DOI":"10.1126\/science.286.5447.2176"},{"key":"2022061620092067700_B26","doi-asserted-by":"crossref","unstructured":"Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet, 26:\u2008109-13, \u20082000.","DOI":"10.1038\/79075"},{"key":"2022061620092067700_B27","doi-asserted-by":"crossref","unstructured":"Cardiff RD, Anver MR, Gusterson BA, et al The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene, 19:\u2008968-88, \u20082000.","DOI":"10.1038\/sj.onc.1203277"},{"key":"2022061620092067700_B28","doi-asserted-by":"crossref","unstructured":"Weiss WA, Israel M, Cobbs C, et al Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene, 21:\u20087453-63, \u20082002.","DOI":"10.1038\/sj.onc.1205936"},{"key":"2022061620092067700_B29","unstructured":"Kleihues P, Cavanee WK . Pathology and genetics. Tumors of the nervous system, IARC Lyon, France \u20082000."},{"key":"2022061620092067700_B30","unstructured":"Scheithauer BW, Woodruff JM, Erlandson RA . Tumors of the peripheral nervous system. Atlas of tumor pathology, vol. 24: Armed Forces Institute of Pathology Bethesda, MD \u20081999."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/10\/3718\/2514326\/zch01004003718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/10\/3718\/2514326\/zch01004003718.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T03:30:14Z","timestamp":1706585414000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/10\/3718\/511254\/Comparative-Pathology-of-Nerve-Sheath-Tumors-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,15]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2004,5,17]]},"published-print":{"date-parts":[[2004,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-03-4079","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,15]]}}}